DROSHA and myelodysplastic syndrome: Three miRNAs (miR-155, miR-181a and miR-222) had significantly decreased expression in MDS-MSCs compared to healthy donors and these are known to target DICER1 and DROSHA, members of the canonical miRNA biogenesis pathway [166].